Literature DB >> 28701053

MicroRNA-613 inhibits the progression of gastric cancer by targeting CDK9.

Yebin Lu1, Ling Tang2, Qi Zhang1, Zhipeng Zhang1, Wei Wei1.   

Abstract

MicroRNAs (miRNAs) play an important role in the development and progression of human malignancy. miR-613, as a tumour suppressor, was reported to decrease in several tumours. However, the expression levels and role of miR-613 in gastric cancer remain unknown. In this study, we found that miR-613 was evidently downregulated in gastric cancer tissue and cell. The functional analysis showed that miR-613 suppressed cell proliferation and migration in gastric cancer. Next, the dual-luciferase reporter system supported CDK9 as a direct target gene of miR-613. miR-613 mimics evidently repressed CDK9 expression in gastric cancer cells. Furthermore, we found that CDK9 in upregulated in gastric cancer and the CDK9 expression levels were inversely correlated with that of miR-613 in gastric cancer tissues. Overall, the results revealed that miR-613, as a tumour suppressor, involves in gastric cancer progression and metastasis by targeting CDK9, implying a novel potential therapeutic target for the treatment of gastric cancer.

Entities:  

Keywords:  CDK9; gastric cancer; miR-613; migration; proliferation

Mesh:

Substances:

Year:  2017        PMID: 28701053     DOI: 10.1080/21691401.2017.1351983

Source DB:  PubMed          Journal:  Artif Cells Nanomed Biotechnol        ISSN: 2169-1401            Impact factor:   5.678


  16 in total

1.  Flavopiridol Mitigates the Progression of Monocrotaline-Induced Pulmonary Hypertension in Rats by Targeting Cyclin-Dependent Kinase 9.

Authors:  Qi Jia; Zhiqiang Hu; Nannan Song; Weike Mao
Journal:  Cardiovasc Drugs Ther       Date:  2022-01-28       Impact factor: 3.727

2.  LINC02418 promotes colon cancer progression by suppressing apoptosis via interaction with miR-34b-5p/BCL2 axis.

Authors:  Jun Tian; Peng Cui; Yifei Li; Xuequan Yao; Xiaoyu Wu; Zhirong Wang; Chunsheng Li
Journal:  Cancer Cell Int       Date:  2020-09-22       Impact factor: 5.722

3.  Role of miR-520b in non-small cell lung cancer.

Authors:  Linlin Zhang; Shuangquan Yu
Journal:  Exp Ther Med       Date:  2018-09-12       Impact factor: 2.447

4.  LncRNA GAS6-AS2 promotes bladder cancer proliferation and metastasis via GAS6-AS2/miR-298/CDK9 axis.

Authors:  Xin Rui; Li Wang; Huafeng Pan; Tingting Gu; Siliang Shao; Jiangyong Leng
Journal:  J Cell Mol Med       Date:  2018-11-05       Impact factor: 5.310

5.  Long Noncoding RNA HOTAIR Functions as a Competitive Endogenous RNA to Regulate Connexin43 Remodeling in Atrial Fibrillation by Sponging MicroRNA-613.

Authors:  Weiran Dai; Xiaoying Chao; Shanshan Li; Shuang Zhou; Guoqiang Zhong; Zhiyuan Jiang
Journal:  Cardiovasc Ther       Date:  2020-11-17       Impact factor: 3.023

Review 6.  MicroRNAs and Natural Compounds Mediated Regulation of TGF Signaling in Prostate Cancer.

Authors:  Zeeshan Javed; Khushbukhat Khan; Amna Rasheed; Haleema Sadia; Shahid Raza; Bahare Salehi; William C Cho; Javad Sharifi-Rad; Wojciech Koch; Wirginia Kukula-Koch; Anna Głowniak-Lipa; Paweł Helon
Journal:  Front Pharmacol       Date:  2021-01-27       Impact factor: 5.810

7.  Long non-coding RNA MIAT promotes the proliferation and invasion of laryngeal squamous cell carcinoma cells by sponging microRNA-613.

Authors:  Fucun Song; Yang Yang; Jixiang Liu
Journal:  Exp Ther Med       Date:  2021-01-21       Impact factor: 2.447

Review 8.  CDK10 in Gastrointestinal Cancers: Dual Roles as a Tumor Suppressor and Oncogene.

Authors:  Zainab A Bazzi; Isabella T Tai
Journal:  Front Oncol       Date:  2021-06-30       Impact factor: 6.244

9.  Potential miRNA-target interactions for the screening of gastric carcinoma development in gastric adenoma/dysplasia.

Authors:  Yu Jin Kim; Ki-Chul Hwang; Sang Woo Kim; Yong Chan Lee
Journal:  Int J Med Sci       Date:  2018-03-14       Impact factor: 3.738

10.  Aberrant CDK9 expression within chordoma tissues and the therapeutic potential of a selective CDK9 inhibitor LDC000067.

Authors:  Shen Shen; Dylan C Dean; Zujiang Yu; Francis Hornicek; Quancheng Kan; Zhenfeng Duan
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.